ScoreWhy is Abbott Laboratories ?
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.62 times
2
Healthy long term growth as Operating profit has grown by an annual rate 13.45%
3
The company has declared Positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 9,037 MM
- ROCE(HY) Highest at 31.01%
- DEBT-EQUITY RATIO (HY) Lowest at 12.17 %
4
With ROCE of 13.01%, it has a attractive valuation with a 4.85 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 8.01%, its profits have risen by 140.3% ; the PEG ratio of the company is 0.1
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Abbott Laboratories should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Abbott Laboratories for you?
Low Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Abbott Laboratories
11.78%
0.66
22.12%
S&P 500
11.09%
0.70
20.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.51%
EBIT Growth (5y)
13.45%
EBIT to Interest (avg)
17.68
Debt to EBITDA (avg)
0.62
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.73
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
29.33%
Pledged Shares
0
Institutional Holding
81.24%
ROCE (avg)
151,913.83%
ROE (avg)
280,862.97%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
5.35
EV to EBIT
37.25
EV to EBITDA
25.84
EV to Capital Employed
4.85
EV to Sales
6.32
PEG Ratio
0.14
Dividend Yield
NA
ROCE (Latest)
13.01%
ROE (Latest)
27.70%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend21What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 9,037 MM
ROCE(HY)
Highest at 31.01%
DEBT-EQUITY RATIO
(HY)
Lowest at 12.17 %
DIVIDEND PER SHARE(HY)
Highest at USD 5.82
INTEREST COVERAGE RATIO(Q)
Highest at 2,111.85
RAW MATERIAL COST(Y)
Fallen by -3.23% (YoY
NET PROFIT(9M)
Higher at USD 12,366.09 MM
NET SALES(Q)
Highest at USD 11,142 MM
OPERATING PROFIT(Q)
Highest at USD 2,851 MM
OPERATING PROFIT MARGIN(Q)
Highest at 25.59 %
PRE-TAX PROFIT(Q)
Highest at USD 2,219 MM
-4What is not working for the Company
NET PROFIT(Q)
At USD 1,857.09 MM has Fallen at -45.06%
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.82 times
Here's what is working for Abbott Laboratories
Operating Cash Flow
Highest at USD 9,037 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Interest Coverage Ratio
Highest at 2,111.85
in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Debt-Equity Ratio
Lowest at 12.17 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Dividend per share
Highest at USD 5.82 and Grown
In each year in the last five yearsMOJO Watch
Company is distributing higher dividend from profits generated
DPS (USD)
Net Sales
Highest at USD 11,142 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit
Highest at USD 2,851 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 25.59 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 2,219 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Raw Material Cost
Fallen by -3.23% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Abbott Laboratories
Net Profit
At USD 1,857.09 MM has Fallen at -45.06%
over average net sales of the previous four periods of USD 3,380.39 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Debtors Turnover Ratio
Lowest at 5.82 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
